Загрузка...
Oncogenic mutant RAS signaling activity is rescaled by the ERK/MAPK pathway
Activating mutations in RAS are present in ~ 30% of human tumors, and the resulting aberrations in ERK/MAPK signaling play a central role in oncogenesis. However, the form of these signaling changes is uncertain, with activating RAS mutants linked to both increased and decreased ERK activation in vi...
Сохранить в:
| Опубликовано в: : | Mol Syst Biol |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7569415/ https://ncbi.nlm.nih.gov/pubmed/33073539 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/msb.20209518 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|